Margaret K. Vandervoort

6.2k total citations · 1 hit paper
54 papers, 3.5k citations indexed

About

Margaret K. Vandervoort is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Margaret K. Vandervoort has authored 54 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Genetics, 19 papers in Epidemiology and 13 papers in Surgery. Recurrent topics in Margaret K. Vandervoort's work include Inflammatory Bowel Disease (25 papers), Microscopic Colitis (12 papers) and Multiple Sclerosis Research Studies (11 papers). Margaret K. Vandervoort is often cited by papers focused on Inflammatory Bowel Disease (25 papers), Microscopic Colitis (12 papers) and Multiple Sclerosis Research Studies (11 papers). Margaret K. Vandervoort collaborates with scholars based in Canada, United States and Netherlands. Margaret K. Vandervoort's co-authors include Brian G. Feagan, John H. Noseworthy, George C. Ebers, Guangyong Zou, Gordon R. Greenberg, Cindy J. Wong, William J. Sandborn, Pierre Paré, Albert Cohen and Geert D’Haens and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Gastroenterology.

In The Last Decade

Margaret K. Vandervoort

53 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treatment of Ulcerative Colitis with a Humanized Antibody to the α ₄ β ₇ Integrin

2005 535 citations Brian G. Feagan, Gordon R. Greenberg et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Margaret K. Vandervoort

Since Specialization

Citations

This map shows the geographic impact of Margaret K. Vandervoort's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margaret K. Vandervoort with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margaret K. Vandervoort more than expected).

Fields of papers citing papers by Margaret K. Vandervoort

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margaret K. Vandervoort. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margaret K. Vandervoort. The network helps show where Margaret K. Vandervoort may publish in the future.

Co-authorship network of co-authors of Margaret K. Vandervoort

This figure shows the co-authorship network connecting the top 25 collaborators of Margaret K. Vandervoort. A scholar is included among the top collaborators of Margaret K. Vandervoort based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margaret K. Vandervoort. Margaret K. Vandervoort is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Randomised non‐inferiority trial: 1600 mg versus 400 mg tablets of mesalazine for the treatment of mild‐to‐moderate ulcerative colitis 2017 ·Alimentary Pharmacology & Therapeutics ·Geert D’Haens, William J. Sandborn, Guangyong Zou, Larry Stitt, P. J. Rutgeerts, D. Gilgen, Vipul Jairath, Pieter Hindryckx, Lisa M. Shackelton, Margaret K. Vandervoort, Claire E. Parker, (unknown), Reetesh K. Pai, Olena Levchenko, (unknown), M. Horyński, Е. И. Михайлова, (unknown), (unknown), Brian G. Feagan	38
2	The development of a magnetic resonance imaging index for fistulising Crohn's disease 2017 ·Alimentary Pharmacology & Therapeutics ·Mark Samaan, Carl A. J. Puylaert, Barrett G. Levesque, Guangyong Zou, Larry Stitt, Stuart A. Taylor, Lisa M. Shackelton, Margaret K. Vandervoort, Reena Khanna, Cynthia Santillan, Jordi Rimola, Pieter Hindryckx, C. Yung Nio, William J. Sandborn, Geert D’Haens, Brian G. Feagan, Vipul Jairath, Jaap Stoker	54
3	Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial 2015 ·The Lancet ·Reena Khanna, Brian Bressler, Barrett G. Levesque, Guangyong Zou, Larry Stitt, Gordon R. Greenberg, Remo Panaccione, Alain Bitton, Pierre Paré, Séverine Vermeire, Geert D’Haens, Donald MacIntosh, William J. Sandborn, Allan Donner, Margaret K. Vandervoort, (unknown), Brian G. Feagan	302
4	Histologic Evaluation of Ulcerative Colitis 2014 ·Inflammatory Bowel Diseases ·Mahmoud Mosli, Brian G. Feagan, William J. Sandborn, Geert D’Haens, Cynthia Behling, Keith J. Kaplan, David K. Driman, Lisa M. Shackelton, Kenneth A Baker, John K MacDonald, Margaret K. Vandervoort, Karel Geboes, Barrett G. Levesque	80
5	A randomised, double-blind, sham-controlled study of granulocyte/monocyte apheresis for moderate to severe Crohn's disease 2012 ·Gut ·Bruce E. Sands, Seymour Katz, Douglas C. Wolf, Brian G. Feagan, Tao Wang, (unknown), Cindy J. Wong, Margaret K. Vandervoort, Stephen B. Hanauer	37
6	Barriers to Blood Pressure Control: A STITCH Substudy 2010 ·Journal of Clinical Hypertension ·Sigrid Nelson, George K. Dresser, Margaret K. Vandervoort, Cindy J. Wong, Brian G. Feagan, Jeffrey L. Mahon, Ross D. Feldman	31
7	A Simplified Approach to the Treatment of Uncomplicated Hypertension 2009 ·Hypertension ·Ross D. Feldman, Guangyong Zou, Margaret K. Vandervoort, Cindy J. Wong, Sigrid Nelson, Brian G. Feagan	161
8	A Randomized, Double-Blind, Sham-Controlled Study of Granulocyte/Monocyte Apheresis for Active Ulcerative Colitis 2008 ·Gastroenterology ·Bruce E. Sands, William J. Sandborn, Brian G. Feagan, Robert Löfberg, Toshifumi Hibi∥, Tao Wang, (unknown), Cindy J. Wong, Margaret K. Vandervoort, Stephen B. Hanauer	153
9	Treatment of Active Crohn's Disease With MLN0002, a Humanized Antibody to the α4β7 Integrin 2008 ·Clinical Gastroenterology and Hepatology ·Brian G. Feagan, Gordon R. Greenberg, Gary Wild, Richard N. Fedorak, Pierre Paré, John WD McDonald, Albert Cohen, Alain Bitton, Jeffrey P. Baker, (unknown), Steven B. Landau, Margaret K. Vandervoort, Asit Parikh	227
10	A cluster‐randomized controlled trial of a blood conservation algorithm in patients undergoing total hip joint arthroplasty 2007 ·Transfusion ·Cindy J. Wong, Margaret K. Vandervoort, (unknown), Allan Donner, Guangyong Zou, John K MacDonald, John Freedman, Keyvan Karkouti, Steven J. MacDonald, Brian G. Feagan	47
11	Top 10 Needs of People with Multiple Sclerosis and Their Significant Others 2006 ·Journal of Neuroscience Nursing ·Wilma J. Koopman, (unknown), Margaret K. Vandervoort	40
12	Treatment of Ulcerative Colitis with a Humanized Antibody to the α ₄ β ₇ Integrin breakdown → 2005 ·New England Journal of Medicine ·Brian G. Feagan, Gordon R. Greenberg, Gary Wild, Richard N. Fedorak, Pierre Paré, John WD McDonald, (unknown), Albert Cohen, A. Hillary Steinhart, Steven B. Landau, Rasha Aguzzi, Irving H. Fox, Margaret K. Vandervoort	535
13	A RANDOMIZED CONTROLLED TRIAL OF A HUMANIZED ALPHA4BETA7 ANTIBODY IN ULCERATIVE COLITIS (UC) 2003 ·The American Journal of Gastroenterology ·Brian G. Feagan, Gordon R. Greenberg, Gary Wild, John F. McDonald, Richard N. Fedorak, Pierre Paré, (unknown), (unknown), Julie Krop, Margaret K. Vandervoort	4
14	Combined budesonide and antibiotic therapy for active Crohn's disease: A randomized controlled trial 2002 ·Gastroenterology ·A. Hillary Steinhart, Brian G. Feagan, Cindy J. Wong, Margaret K. Vandervoort, (unknown), Kenneth Croitoru, Ernest G. Seidman, Desmond Leddin, Alain Bitton, Éric Drouin, Albert Cohen, Gordon R. Greenberg	157
15	Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy: A double-blind, sham-controlled, cross-over study 1996 ·Brain ·Angelika F. Hahn, C. F. Bolton, Neelan Pillay, Colin Chalk, Timothy Benstead, Vera Bril, Kenneth H. Shumak, Margaret K. Vandervoort, Thomas E. Feasby	299
16	Serial cranial and spinal cord magnetic resonance imaging in multiple sclerosis 1992 ·Annals of Neurology ·Samuel Wiebe, (unknown), Stephen J. Karlik, (unknown), Margaret K. Vandervoort, (unknown), L. Arthur Hewitt, G Rice, George C. Ebers, John H. Noseworthy	61
17	NMR studies in experimental allergic encephalomyelitis: Factors which contribute to T1 and T2 values 1990 ·Magnetic Resonance in Medicine ·Stephen J. Karlik, J. J. Gilbert, (unknown), Margaret K. Vandervoort, John H. Noseworthy	22
18	Long‐term use of antecubital veins for plasma exchange 1989 ·Transfusion ·(unknown), Kenneth H. Shumak, Margaret K. Vandervoort, (unknown)	22
19	The prevalence of primary sjögren's syndrome in a multiple sclerosis population 1989 ·Annals of Neurology ·John H. Noseworthy, B. Bass, Margaret K. Vandervoort, George C. Ebers, George P. Rice, Brian G. Weinshenker, (unknown), David A. Bell	52
20	Coronary care unit utilization in Hamilton, Ontario, a city of 375,000 people. 1988 ·PubMed ·John A. Cairns, Joel Singer, M Gent, (unknown), (unknown), David L. Sackett, Brian J. Sealey, Paul H. Tanser, Margaret K. Vandervoort	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact